ClinicalTrials.Veeva

Menu

Neurobehavioral Signatures of Sign- and Goal-Tracking in Emerging Adults: Translation of a Preclinical Model (SIGN)

University of Michigan logo

University of Michigan

Status

Enrolling

Conditions

Healthy
Substance Use

Treatments

Behavioral: Behavioral tasks and eye tracking
Device: fMRI
Behavioral: Questionnaires and surveys

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07094061
R01DA058010 (U.S. NIH Grant/Contract)
HUM00269332

Details and patient eligibility

About

This study seeks to understand individual differences in personality, brain function, and behavior.

Study hypothesis:

- A stronger sign-tracking bias will be associated with a bottom-up processing style characterized by less adaptive attentional- and impulse-control as well as hyperactive reward processing, whereas a stronger goal-tracking bias will be associated with a top-down processing style characterized by strong attentional- and impulse-control as well as normative reward processing.

Enrollment

294 estimated patients

Sex

All

Ages

18 to 20 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-20 years old at baseline
  • Right-handed
  • Medically/physically able to give informed consent
  • English-speaking
  • Substance use is free to vary, but for participants with a history of substance use, ≥ 1 use of cannabis (including less than a full dose)

Exclusion criteria

  • Acute or chronic medical or neurological illness (e.g., diabetes, epilepsy, migraine)
  • History of psychosis in self or first-degree relative
  • Current treatment for substance use disorder
  • Current or past 6-month treatment with centrally acting medications (not including attention deficit hyperactivity disorder (ADHD) medication)
  • Intelligence quotient (IQ) < 70
  • Lifetime history of head trauma with loss of consciousness > 5 minutes
  • Reliance on glasses to be able to read small text at a distance of approximately 30 inches
  • Colorblindness
  • MRI contraindication (e.g., pregnancy, metal implants, claustrophobia) per protocol

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

294 participants in 1 patient group

Assessment group
Experimental group
Treatment:
Behavioral: Questionnaires and surveys
Device: fMRI
Behavioral: Behavioral tasks and eye tracking

Trial contacts and locations

2

Loading...

Central trial contact

Paul Holdefer, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems